Novo Nordisk ADR (NYSE: NVO) is -54.35% lower on its value in year-to-date trading and has touched a low of $57.00 and a high of $139.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $65.29 in the last trading session, with the day’s loss setting it -0.98%.
Currently trading at $64.31, the stock is -6.59% and -8.26% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 8.03 million and changing -1.50% at the moment leaves the stock -24.80% off its SMA200. NVO registered -25.24% loss for a year compared to 6-month loss of -22.44%. The firm has a 50-day simple moving average (SMA 50) of $70.1002 and a 200-day simple moving average (SMA200) of $85.51465.
The stock witnessed a -13.49% gain in the last 1 month and extending the period to 3 months gives it a 2.27%, and is -6.70% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.44% over the week and 2.14% over the month.
Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $216.48B and $43.59B in sales. Current P/E ratio is 19.07 and Fwd P/E is 13.64. Profit margin for the company is 34.52%. Distance from 52-week low is 12.82% and -53.98% from its 52-week high. The company has generated returns on investments over the last 12 months (44.25%).
with sales reaching $76.88B over the same period.The EPS is expected to grow by 29.08% this year, but quarterly earnings will post 14.11% year-over-year. Quarterly sales are estimated to grow 12.96% in year-over-year returns.
Novo Nordisk ADR (NVO) Top Institutional Holders
1789.0 institutions hold shares in Novo Nordisk ADR (NVO), with institutional investors hold 9.85% of the company’s shares. The shares outstanding are 3.37B, and float is at 3.37B with Short Float at 0.76%. Institutions hold 9.85% of the Float.
The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.476% of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $2.78 billion to account for 0.4373 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3272% and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3183 of the shares totaling 14.19 million with a market value of $2.03 billion.
Novo Nordisk ADR (NVO) Insider Activity
#####
